Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lung tissue T cells are activated in chronic obstructive pulmonary disease with non-small cell lung cancer patients.

Scientific reports·2025

Same author

[Thoracoscopic Wedge Resection of Pulmonary Carcinoma with Myelofibrosis while Managing Thrombocytopenia:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2025

Same author

Intraoperative diaphragmatic plication during initial surgery with phrenic nerve resection.

Interdisciplinary cardiovascular and thoracic surgery·2025

Same author

Medical Practice Guidelines for Lung Cancers including malignant pleural mesotheliomas and thymic tumors according to evidence-based medicine. 2024. Edited by the Japan Lung Cancer Society. Chapter 3 Guidelines for thymic epithelial tumors - Summary of recommendations.

Respiratory investigation·2025

Same author

Peripheral CD4<sup>+</sup> T Cells Predict T Cell Immunity in Lung Tissues of Non-small Cell Lung Cancer Patients.

Anticancer research·2025

Same author

Prevalence and causes of subacute cough in Japan.

Respiratory investigation·2024

Search research articles

Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Eosinophilic Pneumonia Putatively Induced by Vancomycin: A Case Report.

Tomomi Isono¹, Hirochiyo Sawaguchi², Hidenori Kusumoto¹

¹Department of General Thoracic Surgery, Kindai University Nara Hospital, Ikoma, Nara, Japan.

The American Journal of Case Reports

|October 1, 2019

Summary

This case report suggests vancomycin may cause eosinophilic pneumonia. Prompt discontinuation of the antibiotic and treatment with prednisolone led to symptom improvement.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Related Experiment Videos

Last Updated: Jan 18, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Area of Science:

Pulmonology
Pharmacology
Critical Care Medicine

Background:

Presents a case of eosinophilic pneumonia potentially induced by vancomycin in a patient undergoing maintenance hemodialysis.
Highlights the diagnostic challenges and clinical course of drug-induced lung injury.

Observation:

A 65-year-old male on hemodialysis developed chest pain and dyspnea, later diagnosed with methicillin-resistant Staphylococcus aureus-positive acute pleural empyema.
Computed tomography revealed widespread reticular shadowing, and laboratory tests showed peripheral eosinophilia and a high proportion of eosinophils in bronchoalveolar lavage fluid.

Findings:

Symptoms and laboratory abnormalities resolved rapidly after vancomycin discontinuation and initiation of prednisolone therapy.
The clinical presentation and response to treatment strongly implicated vancomycin as the causative agent for eosinophilic pneumonia and drug-induced lung injury.

Implications:

This case may represent the first reported instance of vancomycin-induced eosinophilic pneumonia.
Emphasizes the importance of considering drug-induced lung injury in patients presenting with unexplained pulmonary symptoms and eosinophilia, particularly those on vancomycin therapy.